Zealand Pharma patent expiration

1. Zegalogue patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US10442847 ZEALAND PHARMA Glucagon analogues
Feb, 2035

(10 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11795204 ZEALAND PHARMA Glucagon analogues
Jan, 2034

(9 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Mar 22, 2026

Drugs and Companies using DASIGLUCAGON HYDROCHLORIDE ingredient

NCE-1 date: 22 March, 2025

Market Authorisation Date: 22 March, 2021

Treatment: Method of treating diabetic hypoglycemia

Dosage: SOLUTION

More Information on Dosage

ZEGALOGUE family patents

Family Patents

2. Zegalogue (autoinjector) patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US10442847 ZEALAND PHARMA Glucagon analogues
Feb, 2035

(10 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11795204 ZEALAND PHARMA Glucagon analogues
Jan, 2034

(9 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Mar 22, 2026

Drugs and Companies using DASIGLUCAGON HYDROCHLORIDE ingredient

NCE-1 date: 22 March, 2025

Market Authorisation Date: 22 March, 2021

Treatment: Method of treating diabetic hypoglycemia

Dosage: SOLUTION

More Information on Dosage

ZEGALOGUE (AUTOINJECTOR) family patents

Family Patents